Cargando…

COVID-19 Vaccine Hesitancy in Israel Immediately Before the Vaccine Operation

The development of a vaccine for COVID-19 presented hope for a way out of the global crisis caused by the virus. However, a potential barrier may be vaccine hesitancy, and identifying the factors that affect it is critical, especially concerning a new vaccine technology. The purpose of this research...

Descripción completa

Detalles Bibliográficos
Autores principales: Teitler-Regev, Sharon, Hon-Snir, Shlomit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: YJBM 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235256/
https://www.ncbi.nlm.nih.gov/pubmed/35782475
_version_ 1784736275947847680
author Teitler-Regev, Sharon
Hon-Snir, Shlomit
author_facet Teitler-Regev, Sharon
Hon-Snir, Shlomit
author_sort Teitler-Regev, Sharon
collection PubMed
description The development of a vaccine for COVID-19 presented hope for a way out of the global crisis caused by the virus. However, a potential barrier may be vaccine hesitancy, and identifying the factors that affect it is critical, especially concerning a new vaccine technology. The purpose of this research is to identify the factors that effects vaccine hesitancy by using a holistic view. The data were collected from 504 people in December 2020, 3 days before the vaccine operation started in Israel. The analysis included three categories of determinants: (1) contextual influences; (2) health records; and (3) perceived health attitudes. The results indicate that different sets of variables affect willingness to accept the vaccine among the whole spectrum of the vaccine-hesitant and the undecided subsample. In the full sample, gender, age, income, influenza vaccine, perceived trust, perceived susceptibility, perceived benefits, and perceived barriers affected vaccine acceptance. The perceived level of suffering from COVID-19 was associated with willingness to vaccinate, and when religious beliefs increased, the intention to vaccinate decreased. For the undecided subsample, the factors included gender, influenza vaccine, trust in the vaccine company, and perceived vaccine benefits and barriers. The results suggest that efforts of governments and health institutions should focus on women and highlight the vaccine as an opportunity to “go back to normal” without worries. Those results will help implement vaccine strategy in the following cases: if infant vaccination is pursued and if emergency vaccines or new vaccine technologies emerge for another pandemic as well.
format Online
Article
Text
id pubmed-9235256
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher YJBM
record_format MEDLINE/PubMed
spelling pubmed-92352562022-06-30 COVID-19 Vaccine Hesitancy in Israel Immediately Before the Vaccine Operation Teitler-Regev, Sharon Hon-Snir, Shlomit Yale J Biol Med Original Contribution The development of a vaccine for COVID-19 presented hope for a way out of the global crisis caused by the virus. However, a potential barrier may be vaccine hesitancy, and identifying the factors that affect it is critical, especially concerning a new vaccine technology. The purpose of this research is to identify the factors that effects vaccine hesitancy by using a holistic view. The data were collected from 504 people in December 2020, 3 days before the vaccine operation started in Israel. The analysis included three categories of determinants: (1) contextual influences; (2) health records; and (3) perceived health attitudes. The results indicate that different sets of variables affect willingness to accept the vaccine among the whole spectrum of the vaccine-hesitant and the undecided subsample. In the full sample, gender, age, income, influenza vaccine, perceived trust, perceived susceptibility, perceived benefits, and perceived barriers affected vaccine acceptance. The perceived level of suffering from COVID-19 was associated with willingness to vaccinate, and when religious beliefs increased, the intention to vaccinate decreased. For the undecided subsample, the factors included gender, influenza vaccine, trust in the vaccine company, and perceived vaccine benefits and barriers. The results suggest that efforts of governments and health institutions should focus on women and highlight the vaccine as an opportunity to “go back to normal” without worries. Those results will help implement vaccine strategy in the following cases: if infant vaccination is pursued and if emergency vaccines or new vaccine technologies emerge for another pandemic as well. YJBM 2022-06-30 /pmc/articles/PMC9235256/ /pubmed/35782475 Text en Copyright ©2022, Yale Journal of Biology and Medicine https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons CC BY-NC license, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use the material for commercial purposes.
spellingShingle Original Contribution
Teitler-Regev, Sharon
Hon-Snir, Shlomit
COVID-19 Vaccine Hesitancy in Israel Immediately Before the Vaccine Operation
title COVID-19 Vaccine Hesitancy in Israel Immediately Before the Vaccine Operation
title_full COVID-19 Vaccine Hesitancy in Israel Immediately Before the Vaccine Operation
title_fullStr COVID-19 Vaccine Hesitancy in Israel Immediately Before the Vaccine Operation
title_full_unstemmed COVID-19 Vaccine Hesitancy in Israel Immediately Before the Vaccine Operation
title_short COVID-19 Vaccine Hesitancy in Israel Immediately Before the Vaccine Operation
title_sort covid-19 vaccine hesitancy in israel immediately before the vaccine operation
topic Original Contribution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235256/
https://www.ncbi.nlm.nih.gov/pubmed/35782475
work_keys_str_mv AT teitlerregevsharon covid19vaccinehesitancyinisraelimmediatelybeforethevaccineoperation
AT honsnirshlomit covid19vaccinehesitancyinisraelimmediatelybeforethevaccineoperation